%0 Journal Article %A Jordi Blasco %A Josep Puig %A Pepus Daunis-i-Estadella %A Eva González %A Juan Jose Fondevila Monso %A Xabier Manso %A Rafael Oteros %A Elvira Jimenez-Gomez %A Isabel Bravo Rey %A Pedro Vega %A Eduardo Murias %A Jose Maria Jimenez %A Antonio López-Rueda %A Arturo Renú %A Sonia Aixut %A Oscar Chirife Chaparro %A Santiago Rosati %A Manuel Moreu %A Sebastian Remollo %A Yeray Aguilar Tejedor %A Mikel Terceño %A Antonio Mosqueira %A Raul G Nogueira %A Luis San Roman %T Balloon guide catheter improvements in thrombectomy outcomes persist despite advances in intracranial aspiration technology %D 2021 %R 10.1136/neurintsurg-2020-017027 %J Journal of NeuroInterventional Surgery %P 773-778 %V 13 %N 9 %X Background First-pass effect (FPE) has been established as a key metric for technical success and strongly correlates with better clinical outcomes. Most data supporting improved outcomes with the use of a balloon guide catheter (BGC) predate the advent of last-generation large-bore intracranial aspiration catheters. We aim to evaluate the impact of BGC in FPE and clinical outcomes in a large cohort of patients treated with contemporary technology.Methods Patients were recruited from the prospectively ongoing ROSSETTI registry. This registry includes all consecutive patients with anterior circulation large-vessel occlusion (LVO) from 10 comprehensive stroke centers in Spain. Demographic, clinical, angiographic, and clinical outcome data were compared between BGC and non-BGC groups. FPE was defined as the achievement of mTICI2c–3 after a single device pass.Results 426 patients were included out of which 271 (63.62%) used BCG. BGC-treated patients had higher FPE rate (45.8% vs 27.7%; P<0.001), higher final mTICI ≥2 c recanalization rate (76.8% vs 50.3%, respectively; P<0.001), shorter procedural time [median (IQR), 30 (19–58) vs 43 (33–71) min; P<0.001], higher NIHSS difference from admission to 24 hours [median (IQR), 8 (2–12) vs 3 (0–10); P=0.001], and lower mortality rate (17.6% vs 29.8%, P=0.026) compared with non-BGC patients. BGC use was an independent predictor of FPE (OR 2.197, 95% CI 1.436 to 3.361; P<0.001), and excellent clinical outcome at 3 months (OR 0.34, 95% CI 0.17 to 0.68; P=0.002).Conclusions Our results support the benefit of BGC use on angiographic and clinical outcomes in anterior circulation LVO ischemic stroke remain significant even when considering recent improvements in intracranial aspiration technology. %U https://jnis.bmj.com/content/neurintsurg/13/9/773.full.pdf